Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.7 |